Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K992508
    Date Cleared
    1999-08-19

    (23 days)

    Product Code
    Regulation Number
    878.4810
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    TSX PROBE, OCULAR CONTACT PROBE;TSX PROBE,OCULAR CONTACT PROBE,SMA

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Contact Transscleral Cyclophotocoagulation (CYC) for the reduction of intra ocular pressure (IOP) in glaucoma patients. This ocular contact probe to be used with marketed (approved) infrared lasers for this procedure. Ablation of the Ciliary Body in glaucoma patients.

    Device Description

    The TSX Probe consists of three basic parts; handgrip, tip and focusing lens and is a presterilized (Ethylene Oxide) disposable contact probe. Its tip is a clear amber medical plastic that is angled to match the curvature of the human eye and therefore allows for the placement of the probe vertically, closest to the limbus. The angle of the contact tip (distal end) conforms to the curvature of the eye. The three-meter 600 um fiber plugs into an HGM SmartScan™ laser or other SMA connection compatible device allows the physician to perform noninvasive contact CYC with marketed (approved) infrared lasers.

    AI/ML Overview

    The provided text is a 510(k) summary for the TSX Probe, a laser delivery device. It describes the device, its intended use, and its substantial equivalence to a predicate device. However, it does not contain any information about acceptance criteria, device performance studies, sample sizes, ground truth establishment, or multi-reader multi-case studies.

    Therefore, I cannot fulfill your request to describe the acceptance criteria and the study that proves the device meets them, as this information is not present in the provided document. The 510(k) submission primarily focuses on establishing substantial equivalence to an existing legally marketed device, not on presenting detailed performance study results against specific acceptance criteria.

    The submission is essentially a declaration that the TSX Probe is similar enough to the Iris G-Probe that it doesn't require a new, full pre-market approval process. It highlights similarities in fiber size, intended use (reduction of IOP in glaucoma patients via CYC), and compatibility with existing lasers.

    The information you're asking for would typically be found in a more comprehensive clinical trial report or a detailed performance validation study, which is not included in this 510(k) summary.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1